" />
SRA Workshop on Scientific Methods for |
|
|
|
8:00 a.m. to 5:00 p.m. Lunch Included |
|
|
|
202 E. Pratt Ave. Baltimore, MD |
|
Sponsored by |
|
and Regulatory Checkbook |
|
Organized by |
|
Law enacted in 1996 (codified at 21 U.S.C. 346a(p)) directs the U.S. Environmental Protection Agency to "develop a screening program, using appropriate validated test systems and other scientifically relevant information, to determine whether certain substances may have an effect in humans that is similar to an effect produced by a naturally occurring estrogen." EPA's implementation of this directive has proved challenging for a number of reasons, including the difficulty of defining "adverse" endocrine effects in humans (mere perturbations of the endocrine system being routine and normal biochemical events), and devising and validating appropriate toxicological test systems that are sufficiently sensitive and specific to achieve the statutory goal.
EPA's Endocrine Disruptor Screening Program (EDSP) consists of a two-tiered testing strategy supplemented, as required by law, with "other relevant scientific information." Tier 1 will screen for potential adverse effects and Tier 2 will characterize human dose-response for (adverse) endocrine effects. However, EPA does not yet have a scientific weight-of-evidence framework for evaluating Tier 1 data and "other scientifically relevant information," both of which the Agency must use to determine whether a substance subjected to Tier 1 testing must proceed to Tier 2.
This workshop has two objectives. First, the morning session will evaluate the Tier 1 test battery to ascertain (a) whether Tier 1 data can satisfy statutory criteria; and (b) if so, how outputs from Tier 1 and "other relevant scientific information" can be used to develop a (minimally) ordinal or (desirably) cardinal ranking of human endocrine effects that is scientific, transparent, reproducible, and objective.
Second, the afternoon session will focus on selecting and designing "appropriate validated test systems" for estimating dose-response. This is a novel assignment because no established methods now exist for discriminating between adverse and nonadverse endocrine effects and objectively estimating human dose-response. For this reason, the EDSP Tier 2 provides a novel opportunity for innovative scientific work in toxicology, modeling and biostatistics. Registrants will have ample opportunity to participate. The workshop will produce a report suitable for submission to a peer reviewed journal.
Lunch is included.
To register, please go to the SRA website. Space is limited. For hotel reservations, click here.
Workshop Agenda
Time
Speaker/
Discussion
Leader
Topic
0800
Richard
Belzer
Regulatory Checkbook
Mt. Vernon, VA
-
Introduction to the Workshop
-
Introduction to the AM Session
-
Statutory Framework: Federal Food,
Drug and Cosmetic Act (21 U.S.C 346a(p)
-
Statutory Framework: Paperwork
Reduction Act (44 U.S.C. 3501 et seq.)
0830
Steven Lewis
Integrative Policy & Science
Washington, NJ
Theories of Validity in Science
0845
Sue
Marty
Dow Chemical Company
Sensitivity, Selectivity, Variability and Uncertainty in Tier 1 Assays
0930
Tom Vidmar
BioSTAT Consultants
Kalamazoo, MI
Using Tier 1 Data to Rank Chemicals
for Endocrine Effects in Humans
1015
Coffee Break
1030
Warner
North
Northworks
Belmont, CA
Applying "Value of Information" (VOI) Principles to Tier 1 Test Data and "Other Scientifically Relevant Information"
1100
Ray Witorsch
Medical College of Virginia
Virginia Commonwealth University
Richmond, VA
Can Tier 1 Test Data Inform Priority-Setting for Human Health Risk Assessment?
1145
[Interactive]
An ad hoc Experiment in Ranking Tier 1 Data
1230
Buffet Lunch
Included in Registration
1330
Richard Belzer
Regulatory Checkbook
Mt. Vernon, VA
-
Introduction to the PM session
-
Statutory Framework: Information
Quality Act
(44 U.S.C 3516 note)
1400
Harvey Clewell III
The Hamner Institutes
Research Triangle Park, NC
Innovative Methods for Assessing
Human Health Risks from Endocrine-Active Chemicals
1445
Chris Borgert
Applied Pharmacology and Toxicology
Gainesville, FL
Bob
Golden*
ToxLogic
Potomac, MD
1530
Coffee Break
1545
Discussants
Resha Putzrath
U.S. Navy
Portsmouth, VA
Ray Witorsch
Medical College of Virginia
Virginia Commonwealth University
Richmond, VA
1630
Richard
Belzer
Regulatory
Checkbook
Mt. Vernon, VA
-
Summing Up
-
Next Steps
1700
Adjournment
* Invited
Time |
Speaker/ |
Topic |
0800 |
Richard
Belzer |
|
0830 |
Steven Lewis |
Theories of Validity in Science |
0845 |
Sue
Marty |
Sensitivity, Selectivity, Variability and Uncertainty in Tier 1 Assays |
0930 |
Tom Vidmar |
Using Tier 1 Data to Rank Chemicals for Endocrine Effects in Humans |
1015 |
Coffee Break |
|
1030 |
Warner
North |
Applying "Value of Information" (VOI) Principles to Tier 1 Test Data and "Other Scientifically Relevant Information" |
1100 |
Ray Witorsch |
Can Tier 1 Test Data Inform Priority-Setting for Human Health Risk Assessment? |
1145 |
[Interactive] |
An ad hoc Experiment in Ranking Tier 1 Data |
1230 |
Buffet Lunch |
Included in Registration |
1330 |
Richard Belzer |
|
1400 |
Harvey Clewell III |
Innovative Methods for Assessing Human Health Risks from Endocrine-Active Chemicals |
1445 |
Chris Borgert Bob
Golden* |
|
1530 |
Coffee Break |
|
1545 |
Discussants Resha Putzrath Ray Witorsch |
|
1630 |
Richard
Belzer |
|
1700 |
Adjournment |
|
* Invited |
||
| Date: | 6 December 2009 |
